Cargando…

The novel use of mu-opioid receptor antagonism for the treatment of refractory pruritus in Kyrle’s disease()()

Detalles Bibliográficos
Autores principales:	Forouzandeh, Mahtab, Maderal, Andrea D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938818/ https://www.ncbi.nlm.nih.gov/pubmed/31909165 http://dx.doi.org/10.1016/j.ijwd.2019.09.003

Ejemplares similares

Kyrle's disease
por: Azad, Kalpana, et al.
Publicado: (2013)

Dermoscopic pattern of Kyrle's disease()()
por: Ozbagcivan, Ozlem, et al.
Publicado: (2020)

Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and central itch circuits
por: Kim, Brian S., et al.
Publicado: (2022)

A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism
por: Gris, Pavel, et al.
Publicado: (2010)

RARE PRESENTATION OF KYRLE'S DISEASE IN SIBLINGS
por: Viswanathan, Seethalakshmi, et al.
Publicado: (2008)

A Case of Kyrle's Disease with Dermatoscopic Findings
por: Nair, Pragya, et al.
Publicado: (2018)

Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
por: Zamora, Joshua C., et al.
Publicado: (2021)

Generalized Lesions of Kyrle’s Disease: A Rare Case
por: Dharmadji, Hartati Purbo, et al.
Publicado: (2022)

Kyrle's Disease Presenting in an Extensive Distribution along Lines of Blaschko
por: Verma, Rajesh, et al.
Publicado: (2015)

Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade
por: Trøstheim, Martin, et al.
Publicado: (2022)

Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review
por: Bailey, Adrian Joseph Michel, et al.
Publicado: (2022)

The diagnostic process of Kyrle’s disease in a 65-year-old patient
por: Leonik, Szymon, et al.
Publicado: (2021)

Anti-Analgesic Effect of the Mu/Delta Opioid Receptor Heteromer Revealed by Ligand-Biased Antagonism
por: Milan-Lobo, Laura, et al.
Publicado: (2013)

Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications
por: Elmariah, Sarina, et al.
Publicado: (2022)

Kyrle's disease in a patient of diabetes mellitus and chronic renal failure on dialysis
por: Nair, Pragya A., et al.
Publicado: (2015)

Aprepitant for the Treatment of Chronic Refractory Pruritus
por: He, Alice, et al.
Publicado: (2017)

Treatment for Refractory Pruritus Using Oral Aprepitant
por: Huh, Joon Won, et al.
Publicado: (2016)

Kyrle Disease and Acquired Perforating Collagenosis Secondary to Chronic Renal Failure and Diabetes Mellitus
por: Schreml, Stephan, et al.
Publicado: (2011)

Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
por: Peckham, Alyssa M., et al.
Publicado: (2018)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
por: Vidal-Torres, Alba, et al.
Publicado: (2023)

A Case of Infantile Kyrle-Flegel Disease in a 6-Year-Old Yemeni Girl
por: Alshami, Mohammad Ali, et al.
Publicado: (2016)

Neuraxial opioid-induced pruritus: An update
por: Kumar, Kamal, et al.
Publicado: (2013)

Dupilumab for cancer-associated refractory pruritus
por: Talmon, Aviv, et al.
Publicado: (2023)

Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D(2) Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
por: Vasudevan, Lakshmi, et al.
Publicado: (2019)

Treatment Refractory Brachioradial Pruritus Treated with Topical Amitriptyline and Ketamine
por: Magazin, Maja, et al.
Publicado: (2019)

An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function
por: Rozenfeld, Raphael, et al.
Publicado: (2007)

Argon blocks the expression of locomotor sensitization to amphetamine through antagonism at the vesicular monoamine transporter-2 and mu-opioid receptor in the nucleus accumbens
por: David, H N, et al.
Publicado: (2015)

Mu Opioid Receptor Actions in the Lateral Habenula
por: Margolis, Elyssa B., et al.
Publicado: (2016)

Activity of opioid ligands in cells expressing cloned mu opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2003)

Mu Opioid Receptor Gene: New Point Mutations in Opioid Addicts
por: Dinarvand, Amin, et al.
Publicado: (2014)

Mu opioid receptor: from pain to glucose metabolism
por: Tudurí, Eva, et al.
Publicado: (2016)

Systemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient
por: Addepally, Naga S., et al.
Publicado: (2016)

Plasmapheresis for Refractory Pruritus due to Drug-Induced Cholestasis
por: Al-Azzawi, Hasan, et al.
Publicado: (2017)

Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism
por: Giuliano, Chiara, et al.
Publicado: (2013)

Commentary on “Antiseizure activity by opioid receptor antagonism, new evidence”
por: de Witte, Peter
Publicado: (2022)

Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions
por: Liu, Shan, et al.
Publicado: (2021)

Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa–associated refractory pruritus
por: LaMonica, Lauren C., et al.
Publicado: (2023)

Comparison of physicochemical properties and biological activities of opioid morphinans interacting with mu opioid receptors
por: Asim, Muhammad F, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_98hb56e2pvb3kjjmf980lgk6ll